Jump to topic

Our Impact Goals

Graphic of two hands cradling a person figure inside a red circle.

Advance Treatment and Care

Having a variety of effective treatment and care options for symptom management, wellness, and self care will help people on their unique MS journey.

Graphic of a head silhouette with a thumbs up and a wallet icon inside a yellow circle.

Enhance Well-Being

Removing physical and social barriers within communities will ensure access to opportunities and supports for people affected by MS.

Graphic icon of a brain with a stop hand sign, enclosed in a teal circle.

Understand and Halt Disease Progression

Understanding the complexities of MS progression will stop MS in its tracks.

Graphic of a medical shield with a cross symbol inside a blue circle.

Prevent MS

Stopping MS before it starts will reduce the number of people who develop the disease.

Message from the CEO and Chair

Every two hours, someone in Canada is diagnosed with multiple sclerosis (MS). That means that every single day, approximately 12 lives change drastically, carrying a new weight of uncertainty. Canada has one of the highest rates of MS in the world, and with that comes a tremendous responsibility to continuously search for answers, treatments, and solutions – a responsibility we do not take lightly. Our four impact goals drive every decision we make. We work to Advance Treatment and Care, Enhance Well-being, Understand and Halt Disease Progression, and Prevent MS.

For nearly eight decades, MS Canada has transformed the lives of Canadians affected by MS. We are driving innovation in research that is changing how the world understands and treats the disease. Today, we know that when it comes to MS, time matters, and the pace of progress has never been greater. In the last decade alone, breakthroughs in understanding how MS works have fundamentally reshaped treatment and care. Clinicians can now rely on biomarkers and advanced imaging to diagnose MS faster and with more accuracy, allowing for earlier treatment and improved long-term outcomes. We are moving closer to a treatment paradigm that is centred on precision medicine, where MS clinicians can tailor their care to each person’s unique disease course.

We are leading the way in MS prevention research, building a global alliance of MS organizations exploring how to detect MS early, stop it before it causes damage, and advance discoveries that can one day lead us to a world free of MS. This groundbreaking collaboration is uniting experts around the world to understand not only how MS develops, but how to stop it from progressing further and before it starts.

The progress we have seen over the past decades is a direct result of our MS community’s unwavering dedication to a world free of MS. This resilient and dynamic community shares lived experience, drives policy change, and builds powerful networks of connection that raise awareness and offer incredible support. Together, we are paving the way toward a brighter future for all people affected by MS.

Smiling woman with curly blonde hair, wearing a leather jacket and colorful scarf.

Dr. Pamela Valentine
President and CEO,
 MS Canada

Professional headshot of a smiling middle-aged man with glasses, arms crossed, wearing a dark suit.

John Clifford
Board Chair, MS Canada

Canadian neurologist and MS Canada funded researcher, Dr. Kristen Krysko, was awarded the 2025 Rachel Horne Prize for Women’s Research in MS. Dr. Krysko’s pioneering research helps inform the care of women living with MS during pregnancy and breastfeeding

Our Impact Goals in Action- Research at a Glance

One thing is clear: our community shows up. Every year, they bring their skills, interests, and drive to every point of connection they engage in, whether it’s participating in an MS Walk or MS Bike event, volunteering their time, or pursuing a career as researchers catalyzing MS discoveries. Together, we enable progress across all four of our impact goals.

5,091

reclaimed their well-being through our wellness programs

10,090

answered inquiries through our Knowledge Network

183

volunteers and 144 people supported though our Peer 121 program

157

volunteers and 2,818 people supported through our Peer Support groups

1,200

touchpoints about MS awareness month with politicians

80

advocacy meetings with elected officials and government representatives 

71

submissions advocating for policy change

16,625

letters sent by the MS community to elected officials

CN Tower observation deck illuminated in red lights against a dark night sky.
Red MS Canada flag waving on a flagpole against a cloudy sky.

Advancements in Biomarkers and Outcome Measures

This year alone, there have been multiple new biomarker discoveries specifically designed to monitor disease progression and one of its main culprits, Progression Independent of Relapse Activity (PIRA). PIRA has become a central focus in MS research, because it reflects the “silent” worsening of disability that continues even when relapses are under control. By finding ways to measure this often-silent form of progression, neurologists can make more informed treatment decisions to improve care outcomes.

Biomarkers for Progression
Imaging
  • PRLs
  • Cognition
Blood and CSF
  • sNFL
  • GFAP for PIRA
  • CXCL13:BAFF ratio
Clinical Data
  • AI and Machine Learning Models
  • Cognition

Every Gift Counts!

Over 1.4 million

raised through 113,429 gifts under $20

1.89 million

raised with the support of 9,250 monthly donors

Financials

Of the $42.5 million dollars raised in 2025 and the $840,000 dollars drawn from reserves, $43.4 million dollars were invested in life-changing research, advocating for system change, and mobilizing the community to make impact in support of people living with MS as follows:

$23.7 million dollars (55%)

funded life-saving research, programs and advocacy

$15.3 million dollars (35%)

invested in community fundraising activities

$4.2 million dollars (10%)

towards administration